v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities      
Net loss from continuing operations $ (24,489) $ (20,891) $ (27,627)
Adjustments to reconcile net loss to net cash provided by operating activities      
Accretion and accrued interest 7,945 10,862 9,004
Depreciation of property and equipment and amortization of intangible assets 15,621 14,555 14,840
Amortization of operating right-of-use assets 1,595 1,617 1,263
Share-based compensation 5,007 9,706 7,707
Deferred income tax expense recovery (532) 1,368 (10,254)
Loss (gain) on fair value of derivative liabilities 535 (4,549) (181)
Unrealized and realized loss on investments 1,365 238 2,604
(Gain) loss from revaluation of contingent consideration (1,004) 2,465 (645)
Provision for expected credit loss (recovery) 1,665 3,054 0
Loss on extinguishment of debt 1,432 2,096 0
Unrealized and realized foreign exchange (gain) loss (687) 940 2
Impairment and other 2,634 1,249 19,504
Changes in operating assets and liabilities      
Receivables 1,646 (5,302) (8,675)
Inventory 5,946 1,171 (4,250)
Accounts payable and accrued liabilities (4,515) (316) 9,125
Income taxes paid and tax related liabilities 20,498 28,702 39,030
Prepaid expense and other current assets (144) 52 1,135
Other assets and liabilities (592) (801) (694)
Net cash provided by operating activities - continuing operations 33,926 46,216 51,888
Net cash used in operating activities - discontinued operations (12,398) (8,266) (24,417)
Net cash provided by operating activities 21,528 37,950 27,471
Investing activities      
Investment in property and equipment (8,614) (6,866) (4,871)
Investment in note receivable, net of interest received 165 (1,460)  
Investment in intangible assets (738) (1,187) (1,668)
Cash portion of consideration paid in acquisition (5,128) (250) (16,789)
Deposits for business acquisition (3,400)    
Success fees related to Alternative Treatment Center license     (3,012)
Net cash used in investing activities- continuing operations (17,715) (9,763) (26,340)
Net cash provided by (used in) investing activities - discontinued operations 3,108 (2,484) 10,121
Net cash used in investing activities (14,607) (12,247) (16,219)
Financing activities      
Proceeds from loans payable, net of transaction costs 78,944 129,382 23,869
Loan principal paid (70,490) (136,996) (42,759)
Loan exit fee paid (233) (500) (1,178)
Capital distributions paid to non-controlling interests (3,237) (7,324) (11,621)
Payments of contingent consideration (386)    
Payments made for financing obligations and finance lease   (276) (55)
Repurchases of common shares (410) (215)  
Proceeds from private placement, net of share issuance costs     20,820
Proceeds from options exercised     98
Employee retention credit     7,215
Net cash provided by (used in) financing activities- continuing operations 4,188 (15,929) (3,611)
Net cash used in financing activities- discontinued operations   (8,787) (8,889)
Net cash (used in) provided by financing activities 4,188 (24,716) (12,500)
Net increase (decrease) in cash and cash equivalents and restricted cash during the year 11,109 987 (1,248)
Net effects of foreign exchange (572) 653 (168)
Cash and cash equivalents and restricted cash, beginning of the year 26,987 25,347 26,763
Cash and cash equivalents and restricted cash, end of the year 37,524 26,987 25,347
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net 9,403 (5,028) (3,280)
Interest paid 27,938 23,847 23,037
Lease termination fee paid 2,000 271 379
Non-cash transactions      
Equity and warrant liability issued for acquisitions and non-controlling interest 1,278 4,674 8,601
Change in accured capital expenditures (144) (1,098) 1,494
Equity issued for price protection on contingent consideration 1,903 693  
Warrant issued as consideration for services     1,000
Debt instrument issued as consideration for acquisitions 12,980   11,689
Shares issued for legal and liability settlement     794
Federal income tax      
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net 6,466 (7,707) (3,664)
State income tax | NEW JERSEY      
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net 2,805 2,057 200
State income tax | MARYLAND      
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net 1,525 969 (35)
State income tax | PENNSYLVANIA      
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net (1,105) (294) 440
State income tax | Other      
Supplemental disclosure with respect to cash flows      
Cash paid (received) for income tax, net $ (288) $ (53) $ (221)

Source

10-K PDF
XBRL